Skip Ribbon Commands
Skip to main content
Skip over global navigation links
U.S. Department of Health and Human Services
  • HHS Invests in Modernizing U.S. Manufacturing Capacity for Pandemic Influenza Vaccine

    To prepare for the next influenza pandemic, BARDA is investing $226 million to increase U.S. manufacturing capacity of Sanofi Pasteur’s recombinant influenza vaccine, which is faster and more flexible than traditional egg-based technology.

    button 

    Image of the flu viron  


​​​​

PHE Newsroom

Submit an Inquiry

 

Watch, Listen, Subscribe

 
Facebook Twitter YouTube Email via GovDelivery LinkedIn ​​​
​​ ​​ ​​
  • This page last reviewed: December 12, 2019